ZARA, Gian Paolo
 Distribuzione geografica
Continente #
NA - Nord America 7.434
AS - Asia 4.262
EU - Europa 3.959
SA - Sud America 514
AF - Africa 115
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 12
Totale 16.321
Nazione #
US - Stati Uniti d'America 7.256
SG - Singapore 1.558
CN - Cina 1.289
IT - Italia 1.042
IE - Irlanda 446
SE - Svezia 409
BR - Brasile 404
VN - Vietnam 401
DE - Germania 397
FR - Francia 383
FI - Finlandia 333
UA - Ucraina 313
KR - Corea 282
IN - India 183
GB - Regno Unito 178
AT - Austria 140
PL - Polonia 117
CA - Canada 114
HK - Hong Kong 96
BD - Bangladesh 82
JP - Giappone 61
ID - Indonesia 46
RU - Federazione Russa 45
AR - Argentina 43
IQ - Iraq 42
SN - Senegal 39
BE - Belgio 36
TR - Turchia 34
IR - Iran 33
MX - Messico 33
PK - Pakistan 28
NL - Olanda 25
ZA - Sudafrica 25
AU - Australia 22
JO - Giordania 18
TH - Thailandia 18
EG - Egitto 17
ES - Italia 17
CL - Cile 15
UZ - Uzbekistan 15
VE - Venezuela 11
CH - Svizzera 10
CO - Colombia 10
PT - Portogallo 10
RO - Romania 10
BY - Bielorussia 8
JM - Giamaica 8
MU - Mauritius 8
MY - Malesia 8
PY - Paraguay 8
EC - Ecuador 7
EU - Europa 7
LT - Lituania 7
TW - Taiwan 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
IL - Israele 6
MA - Marocco 6
PE - Perù 6
PS - Palestinian Territory 6
TN - Tunisia 6
UY - Uruguay 6
CZ - Repubblica Ceca 5
DK - Danimarca 5
PH - Filippine 5
BO - Bolivia 4
CR - Costa Rica 4
NP - Nepal 4
PA - Panama 4
AL - Albania 3
DZ - Algeria 3
KE - Kenya 3
OM - Oman 3
PR - Porto Rico 3
QA - Qatar 3
RS - Serbia 3
SA - Arabia Saudita 3
SY - Repubblica araba siriana 3
TJ - Tagikistan 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
AP - ???statistics.table.value.countryCode.AP??? 2
BG - Bulgaria 2
EE - Estonia 2
GA - Gabon 2
GR - Grecia 2
HN - Honduras 2
LA - Repubblica Popolare Democratica del Laos 2
MK - Macedonia 2
NI - Nicaragua 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
AI - Anguilla 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BT - Bhutan 1
BW - Botswana 1
Totale 16.299
Città #
Singapore 823
Beijing 789
Chandler 705
Ashburn 583
San Jose 508
Dublin 447
Santa Clara 421
Dallas 322
Jacksonville 255
Fairfield 243
Torino 243
Ann Arbor 242
Houston 218
Milan 152
Woodbridge 147
Medford 144
Nyköping 142
Villeurbanne 135
Vienna 132
Wilmington 132
The Dalles 129
Princeton 128
Columbus 122
Warsaw 112
Dearborn 110
Ho Chi Minh City 109
Los Angeles 105
Lauterbourg 100
Seattle 98
Buffalo 85
Hong Kong 82
Hanoi 80
Pisa 77
Cambridge 70
Helsinki 68
Munich 64
Seoul 63
Rome 62
Fremont 56
New York 55
Dong Ket 52
Hefei 50
Washington 47
Boston 46
Toronto 44
Redwood City 41
Shanghai 39
São Paulo 39
Boardman 38
Verona 38
Brussels 32
Jakarta 31
Guangzhou 29
Nanjing 29
Frankfurt am Main 28
Tokyo 28
Turin 27
Pune 26
Naples 25
Ottawa 22
Turku 21
Council Bluffs 20
Falls Church 20
Norwalk 19
Chennai 17
Chicago 16
London 16
Mumbai 16
Orem 16
Brooklyn 15
Haiphong 15
Nuremberg 15
Phoenix 15
Rio de Janeiro 15
Baghdad 13
Zhengzhou 13
Bangkok 12
Bengaluru 12
Hyderabad 12
Johannesburg 12
Detroit 11
Amman 10
Atlanta 10
Bari 10
Florence 10
Hangzhou 10
Kunming 10
Mexico City 10
Monmouth Junction 10
Biên Hòa 9
Bologna 9
Brasília 9
Cagliari 9
Chengdu 9
Kansas City 9
Karachi 9
Lachine 9
Palermo 9
Santiago 9
Wuhan 9
Totale 9.769
Nome #
GSH-targeted nanosponges increase doxorubicin-induced toxicity "in vitro" and "in vivo" in cancer cells with high antioxidant defenses 454
Solid lipid nanoparticles as promising tool for intraocular tobramycin delivery: Pharmacokinetic studies on rabbits 413
Characterization of biological features of a rat F98 GBM model: a PET-MRI study with [18F]FAZA and [18F]FDG 367
Solid lipid nanoparticles and microemulsions for drug delivery The CNS. 319
Cholesteryl butyrate solid lipid nanoparticles inhibit the adhesion and migration of colon cancer cells. 292
Drug Delivery Nanoparticles in Skin Cancers 291
5-Fluorouracile loaded beta-ctclodextrin nanosponges: in vitro characterisation and cytotoxicity 280
Solid lipid nanoparticles of cholesteryl butyrate inhibit the proliferation of cancer cells in vitro and in vivo models. 278
High energy shock waves and 5-aminolevulinic for sonodynamic therapy: effects in a syngeneic model of colon cancer 238
Baclofen-loaded solid lipid nanoparticles: Preparation, electrophysiological assessment of efficacy, pharmacokinetic and tissue distribution in rats after intraperitoneal administration 233
Azione citotossica in vitro del colesterilbutirrato incorporato in nanoparticelle lipidiche solide 203
Solid lipid nanoparticles for brain tumors therapy: State of the art and novel challenges 197
Cytotoxicity of anticancer drugs incorporated in solid lipid nanoparticles on HT-29 colorectal cancer cell line 194
Antibiotic dosage individualization through Bayesian inference on PK-PD population data 191
Cholesteryl butyrate solid lipid nanoparticles inhibit adhesion and migration of colon cancer cells 188
Determination of disodium clodronate in human plasma and urine using gas-chromatography-nitrogen-phosphorous detection: validation and application in pharmacokinetic study 187
Accumulation and cytotoxic activity of different doxorubicin formulations in human cancer cell lines 185
Application of pharmacoeconomics to the use of antibiotics. 179
Plasma concentrations of 5-fluorouracil and its metabolites in colon cancer patients 179
Innovative formulations for the controlled and site-specific delivery of antiinflammatory drugs 179
Analysis of thiopurine-methyl-transferase (TPMT) genotype and phenotype in a northern Italian population 178
A new apomorphine formulation for oral administration 171
A Non-Parametric Population PK/PD Analysis Of Tolcapone To Predict L-Dopa Plasma Concentrations 168
Modulation of butyrate anticancer activity by solid lipid nanoparticle delivery: an in vitro investigation on human breast cancer and leukemia cell lines 166
Solid lipid nanoparticles as anti-inflammatory drug delivery system in a human inflammatory bowel disease whole blood model 165
Accumulation and cytotoxic activity of different doxorubicin formulations in human cancer cell lines 163
Insulin-Loaded SLN Prepared with the Emulsion Dilution Technique: In Vivo Tracking of Nanoparticles after Oral Administration to Rats 163
Application of Parzaen-based probabilistic neural networks to predict individual plasma concentration from population data 162
Analgesic effect of bisphosphonates in mice. 161
Pharmacokinetics of doxorubicin incorporated in solid lipid nanospheres (SLN). 155
Solid lipid nanoparticles formed by solvent-in-water emulsion diffusion tecnique: development and influence of insulin stability 155
Cytotoxicity of solid lipid nanoparticles incorporating butyric acid and doxorubicin on a human colorectal cancer cell line 154
Solid lipid nanoparticles in lymph and plasma after duodenal administration to rats. 151
5-Aminolevulinic Acid and High Energy Shock Waves for Sonodynamic Therapy: Effects on SK-N-BE and SH-SY5Y Neuroblastoma Cell Lines 150
Different approaches in SLN formulation for cancer therapy 149
GSH-responsive nanoparticles in the treatment of tumor cells. 148
Aminosalycilates do not affect thiopurine-methyl-transferase (TPMT) activity in inflammatory bowel disease (IBD) 147
Cholesteryl butyrate solid lipid nanoparticles as a butyric acid pro-drug: effects on cell proliferation, cell-cycle distribution and c-myc expression in human leukemic cells 146
High Energy Shock Waves (HESW) for Sonodynamic Therapy: Effects on HT-29 Human Colon Cancer Cells 145
Enhanced oral bioavailability of resveratrol using lipid formulations 144
Challangers and Opportunities of Nanoparticle-Based Theranostics in Skin Cancer 144
Transmucosal transport of tobramycin incorporated in SLN after duodenal administration to rats. Part I--a pharmacokinetic study. 141
HPLC determination of 5-FU and three metabolites in the plasma of cancer patients 140
Plasma Erythropoietin levels in patients receiving intensive platinum or non-platinum chemotherapy 138
Transmucosal transport of tobramycin incorporated in solid lipid nanoparticles (SLN) after duodenal administration to rats. Part II--tissue distribution. 135
Atypical chest pain: coronary or esophageal disease? 135
Cholesteryl butyrate solid lipid nanoparticles inhibit adhesion of human neutrophils to endothelial cells 134
Plasma concentrations of 5-Fluorouracil and its metabolites in colon cancer patients 134
SLN per la veicolazione di un analogo fluorescente della Ciclosporina A 133
5-Aminolevulinic Acid and High Energy Shock Waves for Sonodynamic Therapy: effects on SK-N-BE and SH-SY5Y neuroblastoma cell lines 133
Methotrexate loaded SLN prepared by coacervation technique: in vitro cytotoxicity and in vivo pharmacokinetic and biodistribution 132
Plasma immunoerythropoietin levels in patients with cancer receiving platin-based or 5-Fluorouracil-based chemotherapy 130
Validation of a non-parametric approach to predict individual plasma concentrations from population data 130
Thiopurine S-methyltransferase pharmacogenetics on a large-scale healthy Italian caucasian population: difference in enzyme activity 128
[Ambulatory digital manometry] 126
Analgesic, Anti-inflammatory and gastric-damaging effects of dexibuptofen in rodents. 126
Economic impact of resistance in the community. 125
Intracellular accumulation and cytotoxicity of doxorubicin with different pharmaceutical formulations in human cancer cell lines 125
Ophthalmic delivery of dexamethasone and tobramycin incorporated in solid lipid nanoparticles 125
Dexibuprofen (S(+)-isomer Ibuprofen) reduces gastric damage and improves analgesic and antiinflammatory effects in rodents 125
Genotype and phenotype analysis of thiopurine-methyl-transferase (TPMT) in a northern Italian population 124
Dexibuprofen (S+-isomer ibuprofen) reduces gastric damage and improves analgesic and antiinflammatory effects in rodents. 123
Differences between Italian children and adults in thiopurine methyltransferase phenotype and genotype 123
Simultaneous HPLC determination of 5-Fluorouracil and its metabolites in plasma of cancer patients 122
Individualization of Ceftriaxone dosage through Bayesian inference on PK/PD population data 122
Motilin and erythromycin do not affect the motility of rat duodenum in vivo 122
Pharmacokinetics of cyclosporine in recipients of marginal versus standard liver transplants 121
Impact of age in phenothype of thiopurine methyltransferase 121
Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycin 119
Oral bioavailability of Silymarin phytocomplex formulated as self-emulsifying pellets 117
Determination of Ibuprofen in human plasma by high performance liquid chromatography: validation and application in pharmacokinetic study 116
[Anamnestic study of thoracic pain: comparison of angina and gastroesophageal reflux] 115
Thiopurine-methyl-transferase (TPMT) activity in inflammatory bowel disease (IBD) patients is not affected by co-administration of salycilates 115
Phenotype and genotype between italian children and adults for thiopurine methyltransferase 115
Prescriptive styles of general practitioner identified through Bayesian autoclassification method 115
Single dose intramuscolar pharmacokinetics and local tolerability of three different disodium clodronate formulations in healthy volunteers 114
Mesalamine does not impact on thiopurine-methyl-transferase (TPMT) activity in inflammatory bowel disease (IBD) patients 113
Cholesteryl butyrate solid lipid nanoparticles inhibit adhesion of human neutrophils to endothelial cells 113
Pharmacokinetics of disodium clodronate after single intravenous or intramuscolar injection in healthy volunteers 113
CYP3A and MDR1 (P-glycoprotein) gene expression levels along the human gastrointestinal tract 111
Espression of CYP3A Isoforms and P-Glycoprotein in Human Stomach, Jejunum and Ileum 111
Thiopurine S-Methyltransferase Pharmacogenetics on a Large-Scale Healthy Italian-Caucasian Population: Difference in Enzyme Activity among Infant, Children, Adolescent and Adult Subjects 111
Study of thiopurine-methyl-transferase (TPMT) genotype and phenotype in an Italian population 106
[Long-term effects of gastric resection on the inferior esophageal sphincter] 105
Lipid nanoparticles formed by solvent-in-water emulsion-diffusion technique: Development and influence on insulin stability 101
Evaluation of antiproliferative activity of cholesteryl butyrate solid lipid nanospheres on leukemic cell lines 101
Effects of erythromycin on gastrointestinal tract motility. 100
Solid Lipid Nanoparticles carrying oligonucleotides inhibit Vascular Endothelial Grow Factor expression in rat glioma models 99
Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats. 98
Paclitaxel incorporato in nanoparticelle lipidiche solide: studio preliminare farmacocinetico e distribuzione cerebrale 98
Long-term analgesic effect of clodronate in rodents 94
Prevailingly cationic agmatine-based amphoteric polyamidoamine as a nontoxic, nonhemolytic, and stealthlike DNA complexing agent and transfection promoter 93
Cyclodextrin-based nanosponges encapsulating camptothecin: Physicochemical characterization, stability and cytotoxicity 92
[The lower esophageal sphincter in gastrectomized patients. Manometric study] 91
High Energy Shock Waves (HESW) Increase Paclitaxel Efficacy in a Syngeneic Model of Breast Cancer 91
Expression of the Met/HGF receptor in normal and neoplastic human tissues 91
Pharmacokinetics and brain biodistribution of apomorphinne incorporated in solid lipid nanoparticles 91
High Energy Shock Waves increase paclitaxel efficacy in a syngenic model of breast cancer 88
CYP3A and MDR1 (P-glycoprotein) gene expression levels along the human gastrointestinal tract 85
Prediction of individual plasma concentration from population data by the Parzen method 85
Totale 15.112
Categoria #
all - tutte 49.221
article - articoli 0
book - libri 0
conference - conferenze 20.490
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.711


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.212 36 50 20 70 51 32 84 58 35 119 329 328
2022/20231.813 221 150 71 179 136 487 159 100 176 55 57 22
2023/2024738 106 138 63 27 65 133 20 24 8 19 40 95
2024/20252.127 28 98 58 204 593 112 55 105 284 104 144 342
2025/20265.079 512 219 477 510 498 208 703 136 322 508 162 824
2026/2027100 100 0 0 0 0 0 0 0 0 0 0 0
Totale 16.764